No abstract available
MeSH terms
-
2-Pyridinylmethylsulfinylbenzimidazoles
-
Amoxicillin / therapeutic use
-
Animals
-
Anti-Ulcer Agents* / pharmacology
-
Anti-Ulcer Agents* / therapeutic use
-
Carnosine* / analogs & derivatives*
-
Carnosine* / pharmacology
-
Carnosine* / therapeutic use
-
Clarithromycin / therapeutic use
-
Clinical Trials as Topic
-
Drug Resistance, Bacterial
-
Drug Synergism
-
Drug Therapy, Combination
-
Helicobacter Infections / complications
-
Helicobacter Infections / drug therapy*
-
Helicobacter pylori / drug effects
-
Helicobacter pylori / enzymology
-
Humans
-
Lansoprazole
-
Metronidazole / therapeutic use
-
Omeprazole / analogs & derivatives*
-
Omeprazole / therapeutic use
-
Organometallic Compounds* / pharmacology
-
Organometallic Compounds* / therapeutic use
-
Peptic Ulcer / drug therapy
-
Peptic Ulcer / etiology
-
Urease / antagonists & inhibitors
-
Zinc Compounds
Substances
-
2-Pyridinylmethylsulfinylbenzimidazoles
-
Anti-Ulcer Agents
-
Organometallic Compounds
-
Zinc Compounds
-
Lansoprazole
-
polaprezinc
-
Metronidazole
-
Amoxicillin
-
Carnosine
-
Urease
-
Clarithromycin
-
Omeprazole